Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Article (55491299)
Find a Category (125)
Find a Journal (6162)
Find a Scholar (4022)
Find an Academic Assistant (18)
Find an Article PDF (4624134)
Today's Articles (239)
Subscriber (49412)
Citation(s) in
RCA
3
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2013 (1)
2012 (1)
2007 (1)
Show more
Refine
Article Statistics
PubMed (3)
RCA (3)
SCIE (2)
ESCI (1)
Open (1)
Refine
Publication Titles
CHEMOTHERAPY (1)
EXPERT OPINION ON PHARMACOTHERAPY (1)
LUNG CANCER MANAGEMENT (1)
Show more
Refine
Category
Pharmacology & Pharmacy (2)
Oncology (1)
Respiratory System (1)
Show more
Refine
For:
Schuette W
, Blankenburg T, Schneider CP, von Weikersthal LF, Guetz S, Laier-Groeneveld G, Virchow JC, Chemaissani A, Reck M.
Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non-Small-Cell Lung Cancer.
Clin Lung Cancer
2006;
8
:135-9. [PMID:
17026815
DOI:
10.3816/clc.2006.n.042
]
[
Citation(s) in
RCA
: 4
]
[
Impact Index Per Article: 0.2
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/20/2022]
Number
Cited by Other Article(s)
1
Sangal A
, Weiss GJ. Evaluation of contemporary platinum-doublet chemotherapy-modified dose and schedules.
Lung Cancer Manag
2013. [DOI:
10.2217/lmt.13.38
]
[
Citation(s) in
RCA
: 1
]
[
Impact Index Per Article: 0.1
]
[
Reference Citation Analysis
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/21/2022]
Open
Abstract
Collapse
Key Words
Collapse
MESH Headings
Collapse
Grants
Collapse
Affiliation(s)
Ashish Sangal
Cancer Treatment Centers of America, 14200 Celebrate Life Way, Goodyear, AZ 85338, USA
Glen J Weiss
CRAB-Clinical Trials Consortium, Seattle, WA, USA
Collapse
2
Mori K
, Kamiyama Y, Kasai H, Kodama T. A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer.
Chemotherapy
2012;
58
:78-83. [DOI:
10.1159/000335601
]
[
Citation(s) in
RCA
: 3
]
[
Impact Index Per Article: 0.3
]
[
Reference Citation Analysis
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 02/14/2011]
[Accepted: 12/04/2011]
[Indexed: 11/19/2022]
Abstract
Collapse
Key Words
Collapse
MESH Headings
Collapse
Grants
Collapse
Affiliation(s)
Collapse
3
Nagel S
, Califano R, Thatcher N, Blackhall F. Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer.
Expert Opin Pharmacother
2007;
8
:3265-75. [DOI:
10.1517/14656566.8.18.3265
]
[
Citation(s) in
RCA
: 10
]
[
Impact Index Per Article: 0.6
]
[
Reference Citation Analysis
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/05/2022]
Abstract
Collapse
Key Words
Collapse
MESH Headings
Collapse
Grants
Collapse
Affiliation(s)
Collapse
Page 1 of 1
1
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…